Clinical Trial Update: GSK2190915 Neutrophilic Asthma Study [Phase 2]

View source ↗

Summary

The Phase 2 trial of GSK2190915 for neutrophilic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2190915

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED